POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME

POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME was reported 284 times

POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVANAFIL 1 0.0143
1 FINASTERIDE 278 0.0045
2 CICLOPIROX OLAMINE 1 0.0021
3 DUTASTERIDE 11 0.0013
4 DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE 1 0.0003
5 DOXEPIN HYDROCHLORIDE 3 0.0002
6 MINOXIDIL 10 0.0002
7 TAMSULOSIN HYDROCHLORIDE 4 0.0002
8 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE 1 0.0001
9 LETROZOLE TABLETS 4 0.0001
10 ERGOCALCIFEROL 2 0.0001
11 LETROZOLE 4 0.0001
12 RAMIPRIL 8 0.0001
13 TADALAFIL 5 0.0000
14 FLUOXETINE HYDROCHLORIDE 6 0.0000
15 ESCITALOPRAM 6 0.0000
16 AMOXICILLIN 3 0.0000
17 LISDEXAMFETAMINE DIMESYLATE 1 0.0000
18 DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1 0.0000
19 DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE 1 0.0000
20 MELATONIN 1 0.0000
21 METHYLPHENIDATE HYDROCHLORIDE 1 0.0000
22 CITALOPRAM 2 0.0000
23 GABAPENTIN 5 0.0000
24 FISH OIL 1 0.0000
25 VITAMIN C 1 0.0000
26 QUETIAPINE 2 0.0000
27 AMLODIPINE BESYLATE 1 0.0000
28 FOLIC ACID 1 0.0000